HanAll Biopharma logo

HanAll Biopharma

Asia, Seoul-t'ukpyolsi, South Korea, Seoul

Description

HanAll Biopharma World’s Best Bio Pharma for R&D of New Innovative Medicine Respectful Pharmaceutical Company.

Investor Profile

HanAll Biopharma has backed more than 1 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Genetics, Health Care.

Stage Focus

  • Series Unknown (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Genetics
  • Health Care
  • Life Science
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does HanAll Biopharma frequently co-invest with?

Shanda Group
North America, California, United States, Menlo Park
Co-Investments: 1
ThreeD Capital
North America, Ontario, Canada, Toronto
Co-Investments: 1
MF
North America, Virginia, United States, Springfield
Co-Investments: 1
Astellas Venture Management
North America, California, United States, Menlo Park
Co-Investments: 1
Formic Ventures
North America, California, United States, San Francisco
Co-Investments: 1
Daewoong Pharmaceutical
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 1
LongeVC
Europe, Ticino, Switzerland, Lugano
Co-Investments: 1
Khosla Ventures
North America, California, United States, Menlo Park
Co-Investments: 1

What are some of recent deals done by HanAll Biopharma?

Turn.bio

Mountain View, California, United States

Turn.bio is a biotechnology company developing drugs to reverse aging and age-related diseases.

BiotechnologyGeneticsHealth CareLife ScienceTherapeutics
Series UnknownApr 11, 2022

Find More Investors Like HanAll Biopharma

Discover similar investors in our database and build your perfect investor list.

Need help with your fundraising strategy?Read our fundraising guides